• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 66
  • 25
  • 12
  • 8
  • 6
  • 4
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • Tagged with
  • 160
  • 50
  • 45
  • 36
  • 32
  • 32
  • 29
  • 21
  • 19
  • 19
  • 18
  • 18
  • 18
  • 17
  • 17
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
131

Hipertensão arterial e deficit cognitivo

Dias, Eros da Mota 25 July 2012 (has links)
Made available in DSpace on 2016-01-26T12:51:40Z (GMT). No. of bitstreams: 1 erosdamotadias_dissert.pdf: 1356790 bytes, checksum: 1ece28a3152d142febf47e53f4b83f1e (MD5) Previous issue date: 2012-07-25 / Introduction- The role of hypertension in the loss of cognitive function is controversial. Relationships of hypertension with increases in cerebral vascular resistance, diffused lesions and multiple lacunars infarct of the white matter are well known. Objectives- To evaluate the relationship between hypertension and cognitive deficiency (CD), identify risk factors associated with the development of CD and determine the association between markers of early vascular disease and CD in hypertensive individuals. Methods- One hundred and ninety eight individuals aged between 40 and 80 years old were evaluated. Forty eight participants were normotensive (NT). The remaining 150 hypertensive patients were subdivided into two groups, those with CD (HCD) and those without CD (HNCD). All participants underwent clinical evaluations and complete physical examinations and biochemical blood tests were performed. CD was investigated using the Mini Mental State Examination (MMSE) following the guidelines for its use in Brazil. The impact of hypertension on the arterial bed was assessed by identifying and measuring changes in the intima-media thickness (IMT) by vascular ultrasonography of the carotid arteries and analyses of the central blood pressure and Augmentation Index by applanation tonometry of the radial artery. Results- There were no significant differences in the plasma concentrations of total cholesterol, high density lipoprotein cholesterol and triglycerides of the three groups. The serum creatinine and estimated glomerular filtration rate where within normal ranges for all three groups. However, significantly higher values were found for the HCD and HNCD Groups compared to the NT Group (p-value < 0.05). A significantly lower MMSE score was recorded for the HCD Group compared to the HA and NT Groups (p-value < 0.05). The IMT was significantly different between the HNCD and HCD Groups (p-value = 0.0124). A significant difference in the IMT was also observed between hypertensive patients and the NT Group (p-value < 0.0001). The central systolic pressure was significantly higher in the HCD and HNCD Groups compared to NT Group (p-value < 0.0001). There were no significant differences in the Augmentation Index (corrected for heart rate) between the three groups (HNCD, HCD and NT). Conclusions- Hypertensive patients with CD have changes in the vascular morphology characterized by an increased carotid IMT and hemodynamic functional impairment manifested by elevated central systolic blood pressure. / Introdução- O papel da Hipertensão Arterial Sistêmica (HAS) no desenvolvimento de disfunção cognitiva é controverso. Reconhece-se sua relação com o aumento da resistência vascular cerebral e com lesões difusas e infartos lacunares múltiplos na substância branca. Objetivos- Avaliar a relação entre HAS e Déficit Cognitivo (DC), identificar fatores de risco associados a DC e identificar marcadores precoces de doença vascular e DC em hipertensos. Casuística e métodos- Foram avaliados 198 indivíduos com idades entre 40 e 80 anos, dos quais 150 eram hipertensos subdivididos em dois grupos, Hipertensos com DC (HA-DC) e Hipertensos sem DC (HA) e 48 indivíduos normotensos (NT). Todos foram submetidos à avaliação clínica, exame físico completo e exames bioquímicos de sangue. O DC foi investigado mediante o Mini Exame do Estado Metal (MEEM) segundo os critérios cujo uso é recomendado no Brasil. A repercussão da HAS no leito arterial foi rastreada por meio da identificação e quantificação de alteração na Espessura Íntima Média (EIMc) das carótidas com Ultrassonografia Vascular Digital e análise da Pressão Arterial Central (PSC) e do Augmentation Index (AI) mediante Tonometria por Aplanação (TA) da artéria radial. Resultados- As concentrações plasmáticas do colesterol total, colesterol de lipoproteína de alta densidade (HDL) e triglicérides (TG) nos três grupos estudados não mostraram diferenças significantes. Os valores de creatinina sérica e a Taxa de Filtração Glomerular estimada (TFGe) encontram-se dentro da faixa de normalidade nos três grupos. Entretanto valores maiores foram observados nos grupos HA-DC e HA, quando comparados ao grupo NT (p < 0,05). O grupo HA-DC confirmou redução significante do escore do MEEM quando comparado aos grupos HA e NT ( p <0,05). Avaliação da EIMc mostrou diferença significante entre os grupos HA e HA-DC (p=0,0124). Por outro lado, também observamos diferença significante para EIMc entre hipertensos e controles (p < 0,0001). Os grupos HA-DC e HA evidenciaram aumento significante da pressão sistólica central (PSC), quando comparados ao grupo NT (p < 0,0001). Os resultados do Augmentation Index 75 (corrigido para FC), avaliados nos três grupos (HA, HA-DC e NT) não apresentaram diferença significante. Os resultados do presente estudo mostraram: presença de alterações morfológicas caracterizadas por aumento da espessura íntima média das carótidas e alterações funcionais qualificadas como elevação da pressão sistólica central no grupo de hipertensos com DC. Entre os fatores de risco para o desenvolvimento de DC apenas a idade foi associada com déficit do escore do MEEM. Conclusões- Hipertensos com DC apresentam alterações morfológicas vasculares caracterizadas por aumento da espessura íntima média das carótidas e comprometimento hemodinâmico funcional manifesto por elevação de pressão sistólica central.
132

Hardware bidirectional real time motion estimator on a Xilinx Virtex II Pro FPGA

Iqbal, Rashid January 2006 (has links)
<p>This thesis describes the implementation of a real-time, full search, 16x16 bidirectional motion estimation at 24 frames per second with the record performance of 155 Gop/s (1538 ops/pixel) at a high clock rate of 125 MHz. The core of bidirectional motion estimation uses close to 100% FPGA resources with 7 Gbit/s bandwidth to external memory. The architecture allows extremely controlled, macro level floor-planning with parameterized block size, image size, placement coordinates and data words length. The FPGA chip is part of the board that was developed at the Institute of Computer & Communication Networking Engineering, Technical University Braunschweig Germany, in collaboration with Grass Valley Germany in the FlexFilm research project. The goal of the project was to develop hardware and programming methodologies for real-time digital film image processing. Motion estimation core uses FlexWAFE reconfigurable architecture where FPGAs are configured using macro components that consist of weakly programmable address generation units and data stream processing units. Bidirectional motion estimation uses two cores of motion estimation engine (MeEngine) forming main data processing unit for backward and forward motion vectors. The building block of the core of motion estimation is an RPM-macro which represents one processing element and performs 10-bit difference, a comparison, and 19-bit accumulation on the input pixel streams. In order to maximize the throughput between elements, the processing element is replicated and precisely placed side-by-side by using four hierarchal levels, where each level is a very compact entity with its own local control and placement methodology. The achieved speed was further improved by regularly inserting pipeline stages in the processing chain.</p>
133

Hardware bidirectional real time motion estimator on a Xilinx Virtex II Pro FPGA

Iqbal, Rashid January 2006 (has links)
This thesis describes the implementation of a real-time, full search, 16x16 bidirectional motion estimation at 24 frames per second with the record performance of 155 Gop/s (1538 ops/pixel) at a high clock rate of 125 MHz. The core of bidirectional motion estimation uses close to 100% FPGA resources with 7 Gbit/s bandwidth to external memory. The architecture allows extremely controlled, macro level floor-planning with parameterized block size, image size, placement coordinates and data words length. The FPGA chip is part of the board that was developed at the Institute of Computer &amp; Communication Networking Engineering, Technical University Braunschweig Germany, in collaboration with Grass Valley Germany in the FlexFilm research project. The goal of the project was to develop hardware and programming methodologies for real-time digital film image processing. Motion estimation core uses FlexWAFE reconfigurable architecture where FPGAs are configured using macro components that consist of weakly programmable address generation units and data stream processing units. Bidirectional motion estimation uses two cores of motion estimation engine (MeEngine) forming main data processing unit for backward and forward motion vectors. The building block of the core of motion estimation is an RPM-macro which represents one processing element and performs 10-bit difference, a comparison, and 19-bit accumulation on the input pixel streams. In order to maximize the throughput between elements, the processing element is replicated and precisely placed side-by-side by using four hierarchal levels, where each level is a very compact entity with its own local control and placement methodology. The achieved speed was further improved by regularly inserting pipeline stages in the processing chain.
134

Relationship Between the Changes in Placental Blood Flow Resistance Assessed by Doppler Technique and Maternal Serum Placental Aminopeptidases, which Degrade Vaso-Active Peptides, in Pre-Eclampsia

TOMODA, Y, KURAUCHI, O, KASUGAI, M, MIZUTANI, S, ASADA, Y 07 1900 (has links)
名古屋大学博士学位論文 学位の種類 : 博士(医学)(論文) 学位授与年月日:平成4年7月20日 淺田義正氏の博士論文として提出された
135

Βελτιστοποίηση και αυτοματοποίηση τεχνικών μεταγλώττισης μέσω μοντελοποίησης σε επαναπροσδιοριζόμενα συστήματα / Compiler optimization techniques for reconfigurable systems

Δημητρουλάκος, Γρηγόρης 24 October 2007 (has links)
Το αντικείμενο που πραγματεύεται η παρούσα διδακτορική διατριβή σχετίζεται με την ανάπτυξη βελτιστοποιητικών τεχνικών μεταγλώττισης για επαναπροσδιοριζόμενα ολοκληρωμένα συστήματα γενικού και ειδικού σκοπού. Στόχος είναι η βελτιστοποίηση της εκτέλεσης των εφαρμογών ως προς την ταχύτητα, την επιφάνεια ολοκλήρωσης και την κατανάλωση ισχύος. Αυτό επιτυγχάνεται με την εισαγωγή πρωτότυπων τεχνικών μεταγλώττισης αλλά και από την ανεύρεση βέλτιστων αρχιτεκτονικών. Η αυτοματοποίηση των μεθοδολογιών επιτυγχάνεται με την ανάπτυξη εργαλείων βελτιστοποίησης που υλοποιούν την μεθοδολογία μεταγλώττισης. Τα πειράματα έδειξαν γρήγορο προσδιορισμό βέλτιστων λύσεων και σημαντικές βελτιώσεις στην ταχύτητα, επιφάνεια ολοκλήρωσης και κατανάλωση ισχύος για μια σειρά από εφαρμογές ψηφιακής επεξεργασίας σήματος. / The research material that is presented in this PhD Phesis is related with developement of compilation techniques for reconfigurable systems and application specific integrated circuits. The objective is the optimization of the execution of the applications in terms of speed area and power consumption in these architectures. This is achieved by developing original compiling techniques and efficient architecture instances. Moreover, one of the fundamental objectives of this thesis is the automation of these techniques for fast solution determination. Experiments showed that applications are executed faster while keeping the area and power overhead low. The experiments are based on a set of Digital Signal Processing applications.
136

Prävalenz, Risikofaktoren und klinische Ausprägung der systolischen und diastolischen Herzinsuffizienz in einem hausärztlichen Risikokollektiv sowie Wertigkeit echokardiographischer Parameter und natriuretischer Peptide zur Diagnosestellung der diastolischen Herzinsuffizienz / Prevalence, risk factors and clinical characteristics of systolic and diastolic heart failure in patients with risk factors for heart failure from general practitioner`s practice and diagnostic relevance of echocardiography and natriuretic peptides for diastolic heart failure.

Scheele, Frauke 10 August 2011 (has links)
No description available.
137

Rôle du monoxyde d'azote dans la calcification vasculaire et la rigidité artérielle dans un modèle d'hypertension systolique isolée

Gilbert, Liz-Ann 12 1900 (has links)
L’hypertension systolique isolée (HSI) est le résultat de changements au niveau de la paroi vasculaire qui ont pour conséquence d’augmenter la rigidité artérielle. Ces modifications surviennent surtout au niveau des grosses artères comme l’aorte et sont associées au vieillissement. La fragmentation des fibres élastiques, leur calcification (élastocalcinose) et la fibrose font partie des changements majeurs observés avec l’âge. En plus de ces changements, le vieillissement vasculaire provoque des modifications au niveau des cellules qui composent la paroi. Les cellules endothéliales sécrètent moins de monoxyde d’azote (NO) provoquant une dysfonction endothéliale et les cellules musculaires lisses vasculaires (CMLVs) synthétisent maintenant des protéines matricielles et osseuses. Situé entre le sang et les CMLVs, l’endothélium contrôle le tonus vasculaire par la sécrétion de plusieurs substances vasoactives qui interagissent entre elles afin de maintenir l’homéostasie du système vasculaire. Parmi celles-ci, on note l’endothéline (ET), un puissant vasoconstricteur et le NO, un gaz vasorelaxants. Ce dernier est aussi reconnu pour bloquer la production d’ET par un mécanisme dépendant du guanosine monophosphate cyclique (GMPc). Comme il y a une interaction entre le NO et l’ET, et que cette dernière est impliquée dans la calcification artérielle, le NO pourrait être impliqué dans la modulation de l’élastocalcinose et de la rigidité artérielle par l’inhibition de l’ET et la modification de la composition de la paroi. Cet effet, qui se produirait au delà des effets vasorelaxants du NO, offre un potentiel thérapeutique intéressant pour l’HSI. Afin d’évaluer l’implication du NO dans la calcification vasculaire et la rigidité artérielle, un modèle animal d’HSI a été utilisé (modèle warfarine vitamine K, WVK). Ce modèle d’élastocalcinose est basé sur l’inhibition de la maturation d’une protéine anti-calcifiante, la matrix Gla protein (MGP), par la warfarine. Afin de déterminer l’implication physiologique du NO dans l’initiation et la progression de l’élastocalcinose, sa production a été inhibée par un analogue de la L-arginine, le L-NG-nitroarginine methyl ester (L-NAME). Lors des processus d’initiation de la calcification, le L-NAME a prévenu l’élastocalcinose sans toutefois modifier la vitesse de l’onde de pouls (PWV). Suite au traitement L-NAME, l’expression de la NO synthase inductible (iNOS) a été diminuée alors qu’elle a été augmentée lors du traitement WVK. Elle pourrait donc être impliquée dans les processus de calcification vasculaire. De plus, la NO synthase endothéliale (eNOS) semble également impliquée puisqu’elle a été augmentée dans le modèle WVK. Cette hausse pourrait être bénéfique pour limiter l’élastocalcinose alors que l’expression de la iNOS serait délétère. Lors de la progression de la calcification, le L-NAME a augmenté l’élastocalcinose et le PWV. Dans ce contexte, l’ET serait impliquée dans l’amplification de la calcification vasculaire entrainant une hausse de la rigidité artérielle. Comme le NO endogène limite la progression de la calcification et conséquemment la rigidité artérielle, il semble être protecteur. L’efficacité d’une modulation de la voie du NO dans le modèle WVK a été étudiée par l’administration d’un donneur de NO, le sinitrodil, ou d’un inhibiteur de la phosphosdiestérase 5 (PDE5), le tadalafil. La modulation de la voie du NO semble être bénéfique sur la rigidité artérielle, mais seulement de façon aiguë. En effet, le sinitrodil a modifié de transitoirement la rigidité au niveau de l’aorte possiblement par la modulation du tonus vasculaire sans toutefois avoir des effets sur la composition de la paroi. Comme le modèle WVK n’affecte pas la fonction endothéliale, les concentrations endogènes de NO semblent être optimales puisque le sinitrodil provoque une augmentation de l’élastocalcinose possiblement par le développement d’une tolérance. Tout comme le sinitrodil, le tadalafil a modulé de manière aiguë la rigidité artérielle sans modifier la composition de la paroi. Globalement, ces travaux ont permis de mettre en évidence les effets bénéfiques du NO endogène pour limiter le développement de l’HSI, suggérant qu’une dysfonction endothéliale, tel qu’observé lors du vieillissement, a un impact négatif sur la maladie. / Isolated systolic hypertension (ISH) is the result of complex changes in the vascular wall and consequently the increase of arterial stiffness. These modifications occur mainly in conductance arteries, like the aorta, and are associated with aging. The fragmentation of elastic fibers, calcification (elastocalcinosis), and fibrosis are major changes with age. In addition to these changes in the extracellular matrix, vascular aging also induces vascular cell wall modifications. These include decreased production of nitric oxide (NO) by endothelial cells, which induces endothelial dysfunction, and the production of matrix and bone proteins by vascular smooth muscle cells (VSMCs). Located between the blood and VSMCs, the endothelium controls vascular tone by secreting various vasoactive factors. These factors interact with each other to maintain the hemodynamic of the vascular system. Among these factors, the vasoconstrictor endothelin (ET) and the vasodilator NO. The latter has been shown to block ET production via a cyclic guanosine monophosphates-(cGMP) dependent mechanism, whereas ET has been implicated in arterial calcification. Therefore, NO might be involved in the modulation of elastocalcinosis and arterial stiffness by inhibiting ET and modifying the vascular wall composition. This effect of NO could offer interesting therapeutic potential for ISH. To evaluate the implication of NO in the vascular calcification and arterial stiffness, an animal model of ISH was used. This model of elastocalcinosis is based on the inhibition of the maturation of the anti-calcific protein, matrix Gla protein (MGP), by warfarin (WVK model). To gain insight into the physiological role of endogenous NO in the initiation and progression of elastocalcinosis, its production was inhibited by the administration of L-NAME. Interestingly, elastocalcinosis was prevented by L-NG-nitroarginine methyl ester (L-NAME) administration without any modifications of the pulse wave velocity (PWV) during the initiation of the calcification processes. After the L-NAME treatment, the expression of inducible NO synthase (iNOS) was decreased, whereas upon treatment with warfarin alone the expression of iNOS was increased, which could be implicated in vascular calcification and arterial stiffness. In addition, endothelial NO synthase (eNOS) seems to be implicated in this process as its expression was also increased upon WVK treatment. This increase could be beneficial to limit elastocalcinosis, whereas the increase in iNOS expression could be harmful. L-NAME administration during the progression of calcification increased elastocalcinosis and PWV. In an endothelial dysfunction context, ET has been shown to be involved in the amplification process of vascular calcification causing an increase in arterial stiffness. As NO limits the progression of calcification and consequently arterial stiffness, endogenous NO seems to be protective in the aorta. The efficacy of exogenous modulation of the NO pathway in the WVK model was studied upon administration of the NO donor, sinitrodil, or the phosphodiesterase type 5 inhibitor (PDE5), tadalafil. The exogenous modulation of the NO pathway seemed to be beneficial for arterial stiffness, but only in an acute manner. Indeed, sinitrodil modified the acute stiffness in the aorta potentially by vascular tone modulation, without having any effect on vascular wall composition. Since endothelial function was not affected upon WVK model, endogenous NO concentrations seem to be optimal. Thus, exogenous NO potentially caused an increase of elastocalcinosis by inducing tolerance to NO. As well as sinitrodil, tadalafil modulated the arterial stiffness in an acute manner without modifying the composition of the vascular wall. Broadly, these studies provide evidence that endogenous NO can limit ISH development, suggesting that endothelial dysfunction, as observed in aging, has a negative impact on this pathology.
138

Modifications de la matrice extracellulaire dans la rigidité artérielle

Moreau, Simon 11 1900 (has links)
La paroi vasculaire est composée de cellules endothéliales, de cellules musculaires lisses vasculaires et de fibroblastes qui sont entourés d’un réseau structuré et complexe de protéines, la matrice extracellulaire. Les interactions réciproques entre la matrice et les cellules sont nécessaires à la croissance, au développement et au remodelage. Or, différents contextes pathologiques entraînent la perturbation de ces interactions et sont la cause de différentes maladies. Au cours du vieillissement, la matrice extracellulaire des grosses artères élastiques est modifiée. Ainsi, les lamelles élastiques de la paroi vasculaire se fragmentent ou sont dégradées, en plus de calcifier. De même, l’accumulation de protéines plus rigides, comme le collagène, entraîne le développement de la fibrose. Ces modulations vont mener à l’augmentation de la rigidité artérielle et au développement de l’hypertension systolique isolée. En utilisant un modèle animal de calcification basé sur l’inhibition d’une protéine anti-calcifiante, la matrix Gla protein, avec la warfarine, nous avons étudié la séquence des événements impliqués dans le développement de l’hypertension systolique isolée. Nous avons observé l’activation précoce et transitoire de MMP-9, puis du TGF-ß, précédant la modulation phénotypique des cellules musculaires lisses vasculaires, la calcification et les changements hémodynamiques. L’inhibition des métalloprotéinases et du TGF-ß a permis de prévenir la calcification vasculaire. Nous avons également étudié le rôle joué par une enzyme de la matrice extracellulaire, la transglutaminase 2, dans le développement de la calcification associée à l’hypertension systolique isolée. À l’aide d’un nouvel inhibiteur de cette enzyme, qui a permis de prévenir la calcification, nous avons établi que la transglutaminase était un élément clé dans le processus pathologique. Ces travaux ont permis de démontré l’intérêt de nouvelles avenues thérapeutiques ciblant directement la matrice extracellulaire, particulièrement la MMP-9, le TGF-ß et la transglutaminase 2, dans la pathologie de l’hypertension systolique isolée. / Within the vascular wall, endothelial cells, vascular smooth muscle cells and fibroblasts are surrounded by a complex and structured network of secreted macromolecules and proteins, the extracellular matrix. Reciprocal interactions between matrix and cells are essential to growth, development and remodeling. However, in pathological situations, the alteration of these interactions can lead to the development of different disease states. With aging, the extracellular matrix of large elastic arteries undergoes several modifications. The elastic lamellae are fragmented or degraded and calcify, whereas more rigid proteins, such as collagen, accumulate and cause fibrosis. These alterations are associated with the stiffening of arteries, which results in the development of isolated systolic hypertension. In order to study the sequence of events occuring in the development of this pathology, we used an animal model of calcification based on the inhibition of a matrix Gla protein, which physiologically prevents calcification, with warfarin. We observed an acute and transient activation of MMP-9 and TGF-ß, which preceded the phenotypic modulation of vascular smooth muscle cells, calcification and changes to hemodynamic parameters. Moreover, the inhibition of MMPs and TGF-ß prevented vascular calcification. We also studied the role of an extracellular matrix enzyme, transglutaminase 2, in the development of vascular calcification associated with isolated systolic hypertension. Using a novel inhibitor of this enzyme, we established a key role for transglutaminase 2 in this pathological process. This thesis demonstrates the relevance of directly targeting the extracellular matrix, particularly MMP-9, TGF-ß and transglutaminase 2, as a novel therapeutic avenue in the treatment of isolated systolic hypertension.
139

Associação da disfunção diastólica de origem hipertensiva com a atividade simpática cardíaca e periférica / Association of diastolic dysfunction of hypertensive origin with cardiac and peripheral sympathetic activity

Silvia Beatriz Paulino Cavasin de Souza 25 August 2011 (has links)
INTRODUÇÂO: A hipertensão arterial sistêmica (HAS) é uma condição clínica com alta prevalência, sendo considerada como o principal fator de risco modificável para o desenvolvimento de insuficiência cardíaca (IC). Dentre os mecanismos relacionados à progressão da HAS para a IC, a hiperatividade simpática e a disfunção endotelial devem ser consideradas. OBJETIVO: Avaliar a modulação do sistema nervoso autônomo (central e periférico), e a função endotelial em pacientes hipertensos com diferentes graus de disfunção diastólica (DD) do ventrículo esquerdo (VE). CASUÍSTICA E MÉTODO: Quarenta e cinco pacientes com HAS, sem outras co-morbidades foram submetidos ao exame de ecoDopplercardiograma tecidual, e foram alocados em três grupos: (GHT) sem alteração funcional ou estrutural cardíacas (n=15, 7 homens, 48±2 anos, IMC 28±1 Kg/m2), (GDD-ar) com diagnóstico prévio de IC diastólica e com DD padrão alteração de relaxamento do VE (n=15, 7 homens, 53±2 anos, IMC 29±1 Kg/m2) e (GDD-pr) com diagnóstico prévio de IC diastólica com padrão pseudonormal ou restritivo de DD do VE (n=15, 9 homens, 51±2 anos, IMC 27±1 Kg/m2). Voluntários saudáveis normotensos (n=14, grupo GNT) pareados para idade, sexo e IMC também foram avaliados. Curvas de pressão arterial (PA) foram registradas de modo contínuo e não invasivo (Finometer®) durante 15 minutos em repouso, na posição supina. Simultaneamente, a atividade nervosa simpática muscular (ANSM) foi registrada por meio da técnica de microneurografia. A variabilidade da freqüência cardíaca (VFC) e da pressão arterial sistólica (VPAS) foi estimada pelo método FFT. Em um segundo momento foi realizada a avaliação da função endotelial, por meio de ultrassonografia da artéria braquial associada à manobra de hiperemia reativa e após administração de trinitrato sublingual. As análises estatísticas foram realizadas pelo teste exato de Fisher e ANOVA, os resultados expressos em média ± erro padrão ou em mediana (valores mínimos e máximos). RESULTADOS: Não houve diferenças de gênero, idade e IMC entre os grupos, como também no uso das diferentes classes de drogas anti-hipertensivas entre os hipertensos. Os parâmetros estruturais cardíacos foram semelhante entre os grupos, com exceção da massa de VE do grupo GDD-pr [98 (66-162) g/m2] foi maior, p<0,05, quando comparada ao grupo GNT [85 (56-95) g/m2]. A PA sistólica (PAS) não foi diferente entre GHT, GDD-ar e GDD-pr [(138 (110-149), 133 (104-190) e 148 (118-171) mmHg, respectivamente]. Os grupos GDD-ar e GDD-pr apresentaram PAS maiores, p<0,05,quando comparados ao grupo GNT [121(108-133) mmHg]. A PA diastólica foi semelhante entre os grupos. Os grupos mostraram semelhantes valores para a modulação autonômica cardíaca avaliada pela VFC. A modulação simpática periférica representada pelo componente LF PAS da VPAS (mmHg2) foi aumentada nos grupos GDD-ar (12,2±1,3) e GDD-pr (11,7±1,2) quando comparados ao grupo GNT (6,7±0,6), p<0,05, mas não quando comparada ao grupo GHT (9,3±1,1). O prejuízo baroreflexo (índice alfa LF, ms/mmHg) foi observado nos grupos GDD-ar (4,6±0,6) e GDD-pr (5,07±0,7) quando comparados ao grupo GNT (8,2±1), p<0,05, mas não quando comparados ao grupo GHT (6,05±0,5). ANSM (espículas/min) foi maior significativamente nos grupos GDD-ar (33±1) e GDD-pr (32±1) quando comparada aos grupos GHT (26±1) e GNT (15±1) p<0,05. Ainda, o grupo GHT apresentou aumento da ANSM quando comparado ao grupo GNT, p<0,05. Os grupo GDD-ar e GDD-pr apresentaram valores semelhantes de ANSM. Com relação à avaliação da função endotelial, os grupos hipertensos apresentaram menor dilatação dependente do endotélio, sendo que somente no grupo GDD-ar [0,67 (0,0-8,7)%] houve significância estatística quando comparado ao GNT [6,3 (2,6-8,2)%]. Na avaliação da vasodilatação independente do endotélio os grupos apresentaram respostas semelhantes. CONCLUSÃO: A presença de disfunção diastólica, em qualquer grau, está associada à maior ANSM e modulação simpática periférica (LF PAS) e a menor sensibilidade do baroreflexo. A modulação simpática cardíaca não apresentou diferença entre os grupos em repouso. Outros estudos são necessários para esclarecer a relação entre causa - efeito de tais achados / INTRODUTION: The hypertension (HP) is a clinical condition with high prevalence, considered as a main modifiable risk factor for developing heart failure (HF). Among the mechanism related to the progression for HP to the HF, the sympathetic hyperactivity and endothelial dysfunction should be considered. OBJECTIVE: Evaluate the autonomic nervous system modulation (central and peripheral), and endothelial function in hypertensive patients with different pattern of diastolic dysfunction (DD) of the left ventricle (LV). METHOD: Forty-five hypertensive patients without comorbities were submitted to tissue Doppler echocardiography and allocated into three groups: (GHT) without cardiac functional or structural abnormalities (n=15, 7 men, 48±2 years, BMI 28±1 Kg/m2); (GDD-ar) with prior diastolic HF and impaired relaxation pattern of DD of LV (n=15, 7 men, 53±2 years, BMI 29±1 Kg/m2), and (GDD-pr) with prior diastolic HF and pseudonormal and restrictive patterns of DD of LV (n=15, 9 men, 51±2 years, BMI 27±1 Kg/m2). Normotensive healthy volunteers matched for age, sex and body mass index were also evaluated. Curves of blood pressure (BP) were recorded non-invasively and continuously (Finometer®) for 15 minutes at rest in the supine position. Simultaneously, muscle nerve sympathetic activity (MNSA) was recorded by microneurography technique. The heart rate and systolic blood pressure variability (HRV and SPBV) was estimated by FFT method. Afterwards, an evaluation of endothelial function through brachial artery ultrasound maneuver associated with reactive hyperemia and after sublingual administration of trinitrate was conducted. Statistical analysis was performed by Fishers exact test and ANOVA, the results are expressed as mean±standard deviation or median (minimum and maximum values). RESULTS: There were no differences in gender, age and BMI between the groups, as well as in the use of different classes of antihypertensive drugs among hypertensive patients. Cardiac structural parameters were similar between groups, except for LV mass in GDD-pr group [98 (66-162) g/m2] which was higher, p<0.05, when compared to the GNT group [85 (56-95) g/m2]. The systolic blood pressure (SBP) was similar between GHT, GDD-ar and GDD-pr groups [(138 (110-149), 133 (104-190) e 148 (118-171) mmHg, respectively]. The GDD-ar and GDD-pr groups had higher SBP, p<0.05, when compared to GNT group [121(108-133) mmHg]. The diastolic BP was similar between groups. The groups showed similar values for cardiac autonomic modulation assessed by HRV. The peripheral sympathetic modulation represented by the LF component of SBP (SBPV, mmHg2) was increased in GDD-ar group (12,2±1,3) and GDD-pr group (11,7±1,2) compared to the GNT group (6,7±0,6), p<0.05, but not when compared to GHT group (9,3±1,1). The impairment of the baroreflex (LF alpha índex, ms/mmHg) was observed in the GDD-ar (4,6±0,6) e GDD-pr (5,07±0,7) groups compared to the GNT group (8,2±1), p<0.05, but not when compared to GHT group (6,05±0,5). MNSA (burst/min) was significantly higher in GDD-ar (33±1) e GDD-pr (32±1) groups compared to GHT group (26±1) and GNT group (15±1) p<0.05. Also the GHT group showed increased MNSA when compared to GNT group, p<0.05. The GDD-ar and GDD-pr groups showed similar values of MNSA. Regarding the assessment of endothelial function, hypertensive groups had lower endothelium-dependent dilatation, but only in GDD-ar group [0,67 (0,0-8,7)%] was statistically significant when compared to GNT group [6,3 (2,6-8,2)%]. In the evaluation of endothelium-independent vasodilatation all groups showed similar responses. CONCLUSION: The presence of diastolic dysfunction of any pattern is associated with higher MNSA and peripheral sympathetic modulation (LF SBP) and lower sensitivity of the baroreflex. Cardiac sympathetic modulation did not differ between groups at rest. Further studies are needed to clarify the relationship between cause-effect of such findings
140

Comparison between therapeutic efficiency of bone marrow derived mononuclear and mesenchymal stem cells in chronic myocardial infarction

Mathieu, Myrielle 05 May 2009 (has links)
<p>Background: Stem cell therapy can facilitate cardiac repair after healed myocardial infarction but the optimal cell type remains uncertain. <p>Aims: To investigate the pathophysiology of heart failure in a canine model of healed myocardial infarction and to compare the efficacy and the safety of autologous bone marrow mononuclear cell (BMNC) transfer and mesenchymal stem cell (MSC) transfer in this model. It was a blind, randomized and placebo control study.<p>Methods: Eleven weeks after coronary ligation, 24 dogs received intramyocardial injections of BMNC, MSC or Placebo (n = 8 per groups). Echocardiography, conductance method, magnetic resonance imaging, serum neurohormones, holter monitoring, macromorphometry, histology and real time quantitative polymerase chain reaction were used to assess cardiac performance, safety and remodelling in healthy animals, before cell transplantation and up to 16 weeks’ follow-up. <p>Results: The model was characterized by decreased left ventricular end-systolic elastance and ventricular-arterial uncoupling without alteration of compliance. <p>Four months after BMNC transfer, the regional systolic function measured at echocardiographic showed a sustained improvement. This improvement was associated with an improved left ventricular end-systolic elastance and a decreased infarct size. Although the left ventricular ejection fraction stayed unchanged, the serum level of N-terminal B-type natriuretic propeptide level decreased. Mononuclear cell transfer was also associated with increased left ventricular relative wall area, increased vascular density, intramyocardial vascular remodelling and upregulation of angiogenic factors gene expression. Mesenchymal stem cell transfer only improved lately and moderately the regional systolic function, without improvement of cardiac contractility or decreased infarct size. <p>Conclusions: In a canine model of chronic myocardial infarction, BMNC transfer is superior to MSC transfer in improvement of cardiac contractility and regional systolic function, and to reduce the infarct size and plasma N-terminal B-type natriuretic propeptide level. Functional improvement is associated with a favourable angiogenic environment and neovascularization. <p> / Doctorat en Sciences biomédicales et pharmaceutiques / info:eu-repo/semantics/nonPublished

Page generated in 0.0344 seconds